CAM-2029

Thuốc Gốc

Small Molecule

CAM2029 is a new ready-to-use, long-acting octreotide formulation being developed for the long-term treatment of acromegaly, carcinoid syndrome and vasoactive intestinal peptide (VIP)-producing tumours. CAM2029 was found to provide long-acting release of octreotide resulting in a statistically significant suppression of a clinical biomarker insulin-like growth factor 1 (IGF-1) over the target one-month therapeutic period.

Chỉ Định : Investigated for use/treatment in acromegaly and cancer/tumors (unspecified).

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB06063

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading